OTC Derivatives and Trading Platforms in Singapore
Abstract
Singapore is already a major trading hub in the world: it is the eighth largest centre for OTC derivatives.
In a new report, OTC Derivatives and Trading Platforms in Singapore, Celent examines the regulation dynamics, market size, trends in the OTC derivatives market, participant trends, electronic trading, and trading platforms. The proportion of e-trading will continue increasing. The electronic trading rate of CDS, IR, and FX will reach 5%, 15%, and 61% respectively in 2013.

According to the G20 agreement, Singapore Exchange will provide clearing services for many derivatives products, such as NDF. Celent expects this to decline further because there will be greater buy side adoption of algorithmic trading and an increase in speeds once SGX Reach comes online. It will make the market move more trading from OTC to exchanges. Over the next couple of years, SGX will expand this to foreign exchange options, IRS in other currencies, nondeliverable swaps, Asian CDS, indices, and Asian single-name CDSs.
“Celent continues to see a lot of players in the regional IRS markets,” says Hua Zhang, analyst with Celent’s Asian Financial Services group and author of the report, “Regional IRS markets are likely to continue to grow in line with the rise of Asia as a major market in the global economy.”
Celent is a research and advisory firm dedicated to helping financial institutions formulate comprehensive business and technology strategies. Celent publishes reports identifying trends and best practices in financial services technology and conducts consulting engagements for financial institutions looking to use technology to enhance existing business processes or launch new business strategies. With a team of internationally based analysts, Celent is uniquely positioned to offer strategic advice and market insights on a global basis. Celent is a member of the Oliver Wyman Group, which is part of Marsh & McLennan Companies [NYSE: MMC].
Media Contacts
North America (New York)
Dana Greenstein
dgreenstein@celent.com
Tel.: +1 646 364 8254
Europe (Stockholm)
Nick Bockh
nbockh@celent.com
Tel.: +46.8.650.4401
Asia (Tokyo)
Yumi Nagaoka
ynagaoka@celent.com
Tel.: +81.3500.3023
Table of Contents
Executive Summary | 3 | |
Regulatory Dynamics | 4 | |
OTC Derivatives Market Size | 6 | |
OTC FX Derivatives | 7 | |
| OTC FX Spot | 7 |
| OTC FX Forwards | 9 |
| OTC FX Options and NDF | 9 |
| OTC FX Swaps | 10 |
OTC Participants | 12 | |
| OTC IR Participants | 12 |
| OTC FX Participants | 12 |
Electronic Trading Level and Trading Platform | 15 | |
| IR and FX Trading Platform in Exchange | 16 |
| E-Bond Platforms | 17 |
| MarkitSERV | 18 |
| MFX Spot-ON | 19 |
Conclusions | 20 | |
Leveraging Celent’s Expertise | 22 | |
| Support for Financial Institutions | 22 |
| Support for Vendors | 22 |
Related Celent Research | 23 | |